Using myo-inositol during pregnancy to prevent gestational diabetes
Official title: Continuous Glucose Monitoring in Myo-inositol Supplemented Obese Pregnant Individuals: a Feasibility Pilot Randomized Control Trial
Run by Tufts Medical Center · NCT06575868 · Data updated 2026-11-12
This study tests if taking myo-inositol during pregnancy can help prevent gestational diabetes in obese women.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Tufts Medical Center Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | June 30, 2027 |
| Registry record updated | April 29, 2025 |
| Trial ID | NCT06575868 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are obese women aged 18 to 45 years with singleton pregnancies, who are receiving prenatal care at Tufts Medical Center.
✕Probably not a fit
Patients with preexisting diabetes or those taking medications that affect metabolism may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of myo-inositol, an insulin-like compound, on preventing gestational diabetes in pregnant women. It is a double-blind randomized controlled trial where participants will receive either myo-inositol or a placebo. The study aims to assess whether myo-inositol can improve insulin sensitivity and glycemic profiles in obese pregnant women. Participants will be monitored throughout their pregnancy to evaluate the outcomes related to gestational diabetes.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of gestational diabetes among pregnant women, leading to healthier pregnancies and outcomes.
How similar studies have gone: Previous studies have shown promising results with myo-inositol in improving insulin sensitivity in pregnant women, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Singleton gestations Women aged \> 18 years and \< 45 years Recruited before 16 weeks gestation Obese (pre-pregnancy BMI ≥ 30) Receiving prenatal care at Tufts Medical Center Planning to give birth at Tufts Medical Center Can tolerate glucose tolerance test Willing and able to wear CGM Willing and able to sign informed consent Exclusion Criteria: Multiple gestation Preexisting diabetes Taking medications that impact body weight or metabolism (eg metformin) Inability to tolerate glucose tolerance test Adults unable to consent (cognitively impaired adults) Wards of the state Non-viable neonates Neonates of uncertain viability
Where it's running
-
Tufts Medical Center
Boston, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Zeinab Kassem, MD
- Email: zeinab.kassem@tuftsmedicine.org
- Phone: 617-636-9897
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
Interprofessional Training to Improve Care for Peri-Delivery Patients with Substance Use Disorder
This program tests INSPIRE, a set of online and in-person trainings for healthcare teams to reduce stigma and improve care for people with substance use disorder around labor, delivery, and postpartum at the University of Utah.
-
Lower-extremity blood pressure monitoring during cesarean under spinal anesthesia
This study tests whether noninvasive blood pressure monitoring from the toe is better than the arm at predicting neonatal outcomes during cesarean delivery with spinal anesthesia.
-
Care4mommies: a compassion-based approach to support moms-to-be
A compassion-based program with pregnancy-specific content is being tested to see if it helps pregnant people build self-compassion and strengthen the bond with their baby.
-
Eating more eggs during pregnancy to support fetal brain development
This test will see if pregnant women who eat 10–14 eggs per week have better fetal brain development than those who follow a general healthy prenatal diet.
-
See if extra prenatal breastfeeding education helps moms in Inland Empire breastfeed exclusively
This study tests whether supplemental breastfeeding education during pregnancy increases exclusive breastfeeding at 6 weeks after birth for first-time moms or those who didn’t breastfeed long in the past.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.